ALDH2 and retinal disorder: One cross-sectional study (n = 212) demonstrated that proliferative retinopathy prevalence was significantly lower in ALDH2 *2 allele carriers than that in ALDH2 *1/*1 carriers (2.2% vs. 9.2% p<0.05) [10].